Wild-type Transthyretin Amyloid Cardiomyopathy

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-01-03
Clinical Trial Update: A Retrospective Validation Study To Identify Chart-Based Clinical Diagnosis Of Wild-Type Transthyretin Amyloid Cardiomyopathy (Attrwt-CM) And Non-Amyloid Heart Failure Among Patients With Heart Failure (HF).
Pfizer-sponsored retrospective study validating chart-based clinical diagnosis of wild-type transthyretin amyloid cardiomyopathy and non-amy…